The coalition goal is to liberate Mosul by expelling Daesh in a way that minimises the humanitarian impact, civilian casualties and human rights abuses and violations. We have spoken to Coalition partners, including the US and the Government of Iraq and Kurdistan Regional Government, and have made clear that forces taking Mosul need to respect human rights and laws of armed conflict. All training provided by the UK includes Law of Armed Conflict training and an awareness of human rights.<\/p>
Ultimately the forces used will be determined by the Government of Iraq and Kurdistan Regional Government. The Coalition however will not support units which it has concerns about, including certain Shia militia units.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1487", "label" : {"_value" : "Biography information for Mr Tobias Ellwood"} } , "answeringMemberConstituency" : {"_value" : "Bournemouth East"} , "answeringMemberPrinted" : {"_value" : "Mr Tobias Ellwood"} , "dateOfAnswer" : {"_value" : "2016-10-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-10-11T13:22:26.943Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2016-09-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Iraq: Islamic State"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, if he will make representations to the US in respect of coalition obligations to exclude from forces preparing to expel Daesh from Mosul any militias which are assessed as lacking respect for (a) human rights and (b) the laws of war; and what assessment he has made in such regards of the Shiite militia Hashd al-Shaabi.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/54", "label" : {"_value" : "Biography information for Sir Julian Lewis"} } , "tablingMemberConstituency" : {"_value" : "New Forest East"} , "tablingMemberPrinted" : [{"_value" : "Dr Julian Lewis"} ], "uin" : "46544"} , {"_about" : "http://data.parliament.uk/resources/584106", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/584106/answer", "answerText" : {"_value" : "The Foreign and Commonwealth Office (FCO) follows guidance from the UK Advisory Committee on Malaria Prevention (ACMP). The FCO provides medical advice to staff travelling to malarial regions on a case-by-case basis, taking into account factors such as the age of the officer concerned, location and duration of stay. This might in some instances result in an officer being advised to take mefloquine (larium), but no officer is forced to do so. Any staff with concerns are encouraged to discuss with the FCO Healthline or their Regional Medical Advisor, as well as with their local clinic of healthcare provider. The FCO does not hold records on the numbers of staff prescribed mefloquine (larium) and alternative anti-malarial drugs."} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/343", "label" : {"_value" : "Biography information for Sir Alan Duncan"} } , "answeringMemberConstituency" : {"_value" : "Rutland and Melton"} , "answeringMemberPrinted" : {"_value" : "Sir Alan Duncan"} , "dateOfAnswer" : {"_value" : "2016-10-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-10-11T16:48:32.597Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2016-09-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Foreign and Commonwealth Office: Malaria"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, what (a) policy his Department follows and (b) advice his Department gives to staff travelling to malarial regions regarding the use of Lariam as an anti-malarial drug; and what records his Department holds on the number of times (i) Lariam and (ii) alternative anti-malarial drugs have been prescribed to staff in his Department in the last three years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/54", "label" : {"_value" : "Biography information for Sir Julian Lewis"} } , "tablingMemberConstituency" : {"_value" : "New Forest East"} , "tablingMemberPrinted" : [{"_value" : "Dr Julian Lewis"} ], "uin" : "46679"} , {"_about" : "http://data.parliament.uk/resources/528042", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/528042/answer", "answerText" : {"_value" : "
The choice of anti-malarials for Her Majesty's Diplomatic Service Staff and dependants serving overseas has always been based on a stringent individual risk assessment. Recommended anti-malarials will be based on the UK Advisory Committee on Malaria Prevention ( ACMP) guidelines, they will be appropriate for the destination and tailored to the individual, taking into account the possible risks and benefits to the traveller.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1487", "label" : {"_value" : "Biography information for Mr Tobias Ellwood"} } , "answeringMemberConstituency" : {"_value" : "Bournemouth East"} , "answeringMemberPrinted" : {"_value" : "Mr Tobias Ellwood"} , "dateOfAnswer" : {"_value" : "2016-07-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-04T14:01:38.547Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2016-06-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diplomatic Service: Malaria"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, what advice his Department gives to staff of HM Diplomatic Service (a) visiting and (b) posted to malaria-prone countries on use of anti-malarial drugs; whether the Lariam form of mefloquine has been included in a list of approved anti-malarial drugs for staff of his Department; if he will publish the (i) guidelines and (ii) other advice given on anti-malarial drugs to his Department's staff since 2010; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/54", "label" : {"_value" : "Biography information for Sir Julian Lewis"} } , "tablingMemberConstituency" : {"_value" : "New Forest East"} , "tablingMemberPrinted" : [{"_value" : "Dr Julian Lewis"} ], "uin" : "41092"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }